| 000 | 01153 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250512113228.0 | ||
| 264 | 0 | _c19720327 | |
| 008 | 197203s 0 0 eng d | ||
| 022 | _a0009-9236 | ||
| 024 | 7 |
_a10.1002/cpt197213178 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJasinski, D R | |
| 245 | 0 | 0 |
_aEvaluation of nalbuphine for abuse potential. _h[electronic resource] |
| 260 |
_bClinical pharmacology and therapeutics _c |
||
| 300 |
_a78-90 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAnalgesia |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCycloparaffins _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aMorphinans _xadministration & dosage |
| 650 | 0 | 4 |
_aMorphine _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNalorphine _xpharmacology |
| 650 | 0 | 4 |
_aSubstance Withdrawal Syndrome _xdrug therapy |
| 650 | 0 | 4 | _aSubstance-Related Disorders |
| 700 | 1 | _aMansky, P A | |
| 773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 13 _gno. 1 _gp. 78-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/cpt197213178 _zAvailable from publisher's website |
| 999 |
_c4554477 _d4554477 |
||